The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Diabetes Mellitus and the Risk of Cancer: Results From a Large-Scale Population-Based Cohort Study in Japan
Abstract
BACKGROUND: An association between diabetes mellitus (DM) and cancer has long been speculated, but no conclusive evidence has been obtained. METHODS: We prospectively examined the association between a history of DM and subsequent risk of cancer in the Japan Public Health Center-Based Prospective Study. A total of 97 771 general Japanese persons (46 548 men and 51 223 women) aged 40 to 69 years who responded to the baseline questionnaire, from January 1990 to December 1994, were followed up for cancer incidence through December 31, 2003. At baseline, 6.7% of men and 3.1% of women had a history of DM. RESULTS: A total of 6462 cases of newly diagnosed cancer were identified. In men, a 27% increase in the risk of total cancer incidence was observed in those with a history of DM (n = 3907 [366 with DM]; hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.14-1.42). The HR was especially high for those with cancer of the liver (n = 312 [52 with DM]; HR, 2.24; 95% CI, 1.64-3.04), pancreas (n = 118 [16 with DM]; HR, 1.85; 95% CI, 1.07-3.20), and kidney (n = 99 [13 with DM]; HR, 1.92; 95% CI, 1.06-3.46). We also observed a moderately increased risk of colon cancer (n = 491 [46 with DM]; HR, 1.36; 95% CI, 1.00-1.85) and of stomach cancer with borderline significance (n = 977 [87 with DM]; HR, 1.23; 95% CI, 0.98-1.54). In women, a borderline significant increase in risk was observed for the incidence of total cancer (n = 2555 [104 with DM]; HR, 1.21; 95% CI, 0.99-1.47), while statistical significance was observed for the incidence of stomach cancer (n = 362 [20 with DM]; HR, 1.61; 95% CI, 1.02-2.54) and liver cancer (n = 120 [10 with DM]; HR, 1.94; 95% CI, 1.00-3.73) and borderline significance was observed for the incidence of ovarian cancer (n = 74 [5 with DM]; HR, 2.42; 95% CI, 0.96-6.09). CONCLUSION: Patients with DM drawn from the general Japanese population may be at increased risk of total cancer and of cancer in specific sites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The underlying mechanisms of tumorigenesis in T2DM seem to be related to insulin resistance, hyperinsulinemia, elevated levels of IGF-1 [140-142], and hyperglycemia with the latter driving ATP production in cancer cells through the glycolytic pathway, a mechanism known as the Warburg effect [142].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [140]
Citations
Cites
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H. O. M., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,294
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 989
Le Roith, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360907 · Cited by 897
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 848
Giovannucci, E. L. (1995) · Cancer Causes & Control · doi:10.1007/bf00052777 · Cited by 808
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J. M., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 562
Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients
Lo, S., Chang, S., Muo, C., Chen, S., Liao, F., Dee, S., Chen, P., & Sung, F. (2012) · International Journal of Cancer · doi:10.1002/ijc.27597 · Cited by 83
Kasuga, M., Ueki, K., Tajima, N., Noda, M., Ohashi, K., Noto, H., Goto, A., Ogawa, W., Sakai, R., Tsugane, S., et al. (2013) · Cancer Science · doi:10.1111/cas.12203 · Cited by 82
Iglesias, D. A., Yates, M. S., van der Hoeven, D., Rodkey, T. L., Zhang, Q., Co, N. N., Burzawa, J. K., Chigurupati, S., Celestino, J., Bowser, J. L., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0439 · Cited by 81
Breast Cancer Status in Iran: Statistical Analysis of 3010 Cases between 1998 and 2014
Akbari, M. E., Sayad, S., Sayad, S., Khayamzadeh, M., Shojaee, L., Shormeji, Z., & Amiri, M. (2017) · International Journal of Breast Cancer · doi:10.1155/2017/2481021 · Cited by 81
Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies
Miao, Z., Xu, H., Xu, Y.-Y., Wang, Z.-N., Zhao, T., Song, Y., & Xu, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16487 · Cited by 81
Diabetes and risk of bladder cancer
MacKenzie, T. A., Zens, M. S., Ferrara, A. M., Schned, A. R., & Karagas, M. R. (2010) · Cancer · doi:10.1002/cncr.25641 · Cited by 80
Diabetes mellitus and risk of gastric cancer
Ge, Z., Ben, Q., Qian, J., Wang, Y., & Li, Y. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834b8d73 · Cited by 80
Fuchs, O., Sheiner, E., Meirovitz, M., Davidson, E., Sergienko, R., & Kessous, R. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4275-7 · Cited by 78
Cancer Risk in HBV Patients With Statin and Metformin Use
Chen, C.-I., Kuan, C.-F., Fang, Y.-A., Liu, S., Liu, J., Wu, L., Chang, C.-J., Yang, H., Hwang, J., Miser, J. S., et al. (2015) · Medicine · doi:10.1097/md.0000000000000462 · Cited by 77
Häggström, C., Stocks, T., Rapp, K., Bjørge, T., Lindkvist, B., Concin, H., Engeland, A., Manjer, J., Ulmer, H., Selmer, R. M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25521 · Cited by 76
Diabetes mellitus and the risk of bladder cancer
Xu, Y., Huo, R., Chen, X., & Yu, X. (2017) · Medicine · doi:10.1097/md.0000000000008588 · Cited by 76
Chowdhury, T. A. (2010) · QJM · doi:10.1093/qjmed/hcq149 · Cited by 76
Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies
Huang, W., Ren, H., Ben, Q., Cai, Q.-C., Zhu, W., & Li, Z. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9874-9 · Cited by 77
Insulin, Insulin Resistance, Obesity, and Cancer
Gallagher, E. J., & LeRoith, D. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0101-y · Cited by 76
Diabetes mellitus, hyperglycaemia and cancer
Simon, D., & Balkau, B. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.04.001 · Cited by 74
Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis
Gang, P. J., Mo, L., Yang, L., Luo, R., & Xing, Z. (2014) · Endocrine Research · doi:10.3109/07435800.2014.934961 · Cited by 74
Metformin potentiates rapamycin and cisplatin in gastric cancer in mice
Yu, G., Fang, W., Xia, T., Chen, Y., Gao, Y., Jiao, X., Huang, S., Wang, J., Li, Z., & Xie, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3327 · Cited by 74
Zaafar, D. K., Zaitone, S. A., & Moustafa, Y. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100562 · Cited by 76
RetractedRisk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
Björkström, K., Franzén, S., Eliasson, B., Miftaraj, M., Guðbjörnsdóttir, S., Lagerros, Y. T., Svensson, A., & Hagström, H. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.038 · Cited by 75
Systematic review of modifiable risk factors for kidney cancer
Al-Bayati, O., Hasan, A., Pruthi, D. K., Kaushik, D., & Liss, M. A. (2019) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.12.008 · Cited by 74
Diabetes Mellitus Is an Independent Risk Factor for Colorectal Cancer
Sun, L., & Yu, S. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2059-x · Cited by 72
Hidaka, A., Sasazuki, S., Matsuo, K., Ito, H. M., Sawada, N., Shimazu, T., Yamaji, T., Iwasaki, M., Inoue, M., Tsugane, S., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu244 · Cited by 72
Self-citationCancer risk among patients with type 2 diabetes: A real‐world study in Shanghai, China
Qi, J., He, P., Yao, H., Song, R., Ma, C., Cao, M., Cui, B., & Ning, G. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12926 · Cited by 72
Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
Zhu, Z., Zhang, X., Shen, Z., Zhong, S., Wang, X., Lu, Y., & Chen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056662 · Cited by 72
Hagiwara, A., Nishiyama, M., & Ishizaki, S. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22941 · Cited by 71
Development and prognosis of hepatocellular carcinoma in patients with diabetes
Nakatsuka, T., & Tateishi, R. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0095 · Cited by 73
Kim, Y., Kim, S., Cho, S., Park, J., Choi, I. J., Lee, Y. J., Lee, E. K., Kook, M., Kim, C. G., Ryu, K. W., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12660 · Cited by 70
Tworoger, S. S., & Huang, T. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_9 · Cited by 72
The Association Between Metabolic Syndrome and Gastric Cancer in Chinese
Li, F., Du, H., Li, S., & Liu, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00326 · Cited by 69
Starup‐Linde, J., Karlstad, Ø., Eriksen, S. A., Vestergaard, P., Bronsveld, H. K., de Vries, F., Andersen, M., Auvinen, A. P., Haukka, J. K., Hjellvik, V., et al. (2013) · Current Drug Safety · doi:10.2174/15748863113086660071 · Cited by 68
High glucose levels promote the proliferation of breast cancer cells through GTPases
Hou, Y., Zhou, M., Xie, J., Chao, P., Feng, Q., & Wu, J. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s135665 · Cited by 68
Diabetes and Thyroid Cancer Risk: Literature Review
Shih, S., Chiu, W., Chang, T., & Tseng, C. (2012) · Experimental Diabetes Research · doi:10.1155/2012/578285 · Cited by 67
Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma
Donadon, V. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.3025 · Cited by 66
Diabetes mellitus and metformin in hepatocellular carcinoma
Fujita, K., Iwama, H., Miyoshi, H., Tani, J., Oura, K., Tadokoro, T., Sakamoto, T., Nomura, T., Morishita, A., Yoneyama, H., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i27.6100 · Cited by 68
Symposium introduction: metabolic syndrome and the onset of cancer
Zhou, J., Blackburn, G. L., & Walker, W. A. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.817s · Cited by 64
Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
Malaguarnera, R., Vella, V., Nicolosi, M. L., & Belfiore, A. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00314 · Cited by 68
Cdc42: A Novel Regulator of Insulin Secretion and Diabetes-Associated Diseases
Huang, Q.-Y., Lai, X., Qian, X., Lv, L., Li, J., Duan, J., Xiao, X., & Xiong, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010179 · Cited by 67
Noto, H., Tsujimoto, T., & Noda, M. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00183.x · Cited by 63
Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study
Tagalakis, V., Tamim, H., Blostein, M. D., Collet, J., Hanley, J. A., & Kahn, S. R. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70046-3 · Cited by 63
Ma, E., Sasazuki, S., Iwasaki, M., Sawada, N., & Inoue, M. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.04.021 · Cited by 63
Self-citationDesai, M. D., Linehan, D. C., Hawkins, W. G., Strasberg, S. M., Gao, F., & Wang‐Gillam, A. (2011) · Pancreas · doi:10.1097/mpa.0b013e318215a9b1 · Cited by 62
Association of Type 2 Diabetes and Colon Adenomas
Eddi, R., Karki, A., Shah, A. K., DeBari, V. A., & DePasquale, J. R. (2011) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-011-9316-7 · Cited by 61
Hirakawa, Y., Ninomiya, T., Mukai, N., Doi, Y., Hata, J., Fukuhara, M., Iwase, M., Kitazono, T., & Kiyohara, Y. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws178 · Cited by 61
Type II Diabetes, Obesity, and Breast Cancer Risk: The Multiethnic Cohort
Maskarinec, G., Jacobs, S., Park, S., Haiman, C. A., Setiawan, V. W., Wilkens, L. R., & Marchand, L. L. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0789 · Cited by 60
Dey, S., Murmu, N., Mondal, T., Saha, I., Chatterjee, S., Manna, R., Haldar, S., Dash, S. K., Sarkar, T. R., & Giri, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113801 · Cited by 58
Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
Xu, X., Wu, J., Mao, Y., Zhu, Y., Hu, Z., Xu, X., Lin, Y., Chen, H., Zheng, X., Qin, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058079 · Cited by 58
Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis
Luo, S., Li, J., Zhao, L., Yu, T., Zhong, W., Xia, Z., Shan, T., Ouyang, H., Yang, H., & Chen, Q. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.021 · Cited by 58
Guo, J., Liu, C., Pan, J., & Yang, J. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109866 · Cited by 57
Tseng, C., Chong, C.-K., & Tai, T. Y. (2008) · Diabetologia · doi:10.1007/s00125-008-1204-8 · Cited by 57
Motomura, K., Yamashita, H., Yamada, S., Takahashi, Y., & Kaneko, H. (2019) · Rheumatology International · doi:10.1007/s00296-019-04428-z · Cited by 56
Low Glycemic Load Experimental Diet More Satiating Than High Glycemic Load Diet
Chang, K. T., Lampe, J. W., Schwarz, Y., Breymeyer, K. L., Noar, K. A., Song, X., & Neuhouser, M. L. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.676143 · Cited by 59
Prospective Study of Self-Reported Diabetes and Risk of Upper Gastrointestinal Cancers
Lin, S., Freedman, N. D., Hollenbeck, A. R., Schatzkin, A. G., & Abnet, C. C. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1244 · Cited by 56
Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
Chao, C., & Page, J. H. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn160 · Cited by 56
Tseng, C. (2021) · Biomolecules · doi:10.3390/biom11071022 · Cited by 55
Ali, M. A., Hassan, M., Ansari, S. A., Alkahtani, H. M., Al-Rasheed, L. S., & Ansari, S. A. (2024) · Pharmaceuticals · doi:10.3390/ph17060757 · Cited by 61
Michikawa, T., Inoue, M., Sawada, N., Iwasaki, M., Tanaka, Y., Shimazu, T., Sasazuki, S., Yamaji, T., Mizokami, M., & Tsugane, S. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.05.017 · Cited by 54
Self-citationHyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy
Hosokawa, T. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i2.249 · Cited by 54
The Role of Reprogrammed Glucose Metabolism in Cancer
Ediriweera, M. K., & Jayasena, S. (2023) · Metabolites · doi:10.3390/metabo13030345 · Cited by 55
Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis
Qi, C., Zhou, Q., Li, B., Yang, Y., Cao, L., Ye, Y., Li, J., Ding, Y., Wang, H., Wang, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2483 · Cited by 53
Diabetes and risk of incident colorectal cancer in a prospective cohort of women
Flood, A. P., Strayer, L., Schairer, C., & Schatzkin, A. G. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9555-0 · Cited by 53
de Bruijn, K. M. J., Ruiter, R., de Keyser, C. E., Albert Hofman, D., Stricker, B. H. C., & van Eijck, C. H. J. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.019 · Cited by 55
Inoue, M., Kurahashi, N., Iwasaki, M., Tanaka, Y., Mizokami, M., Noda, M., & Tsugane, S. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9287-6 · Cited by 52
Self-citationDiabetes mellitus carries a risk of gastric cancer: A meta-analysis
Shimoyama, S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i40.6902 · Cited by 53
Zou, J., Hong, L., Luo, C., Li, Z., Zhu, Y., Huang, T., Zhang, Y., Yuan, H., Hu, Y., Wen, T., et al. (2016) · Cancer Science · doi:10.1111/cas.13083 · Cited by 53
Hidaka, A., Sasazuki, S., Goto, A., Sawada, N., Shimazu, T., Yamaji, T., Iwasaki, M., Inoue, M., Noda, M., Tajiri, H., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29098 · Cited by 52
Self-citationDiabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan
Chen, Y., Cheng, K. F., Lai, S., Tsai, I., Lin, C.-C., Sung, F., Lin, C., & Chen, P. (2012) · Gastric Cancer · doi:10.1007/s10120-012-0197-7 · Cited by 51
Zhang, D., Li, N., Xi, Y., Zhao, Y., & Wang, T. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.005 · Cited by 50
Shen, D., Deng, C., & Zhang, M. (2007) · Postgraduate Medical Journal · doi:10.1136/pmj.2006.052761 · Cited by 51
Cancer Risk in Type 2 Diabetes Mellitus: Metabolic Links and Therapeutic Considerations
Sun, G. E. C., & Kashyap, S. R. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2011/708183 · Cited by 51
Association between diabetes mellitus and lung cancer: Meta‐analysis
Yi, Z., Agbana, Y. L., Xiong, G., Ni, Y., Yun, F., Chen, J., Yang, Z., Zhang, Q., Kuang, Y., & Zhu, Y. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13332 · Cited by 51
Diabetes mellitus and outcomes of colorectal cancer
Jullumstrø, E., Kollind, M., Lydersen, S., & Edna, T. (2008) · Acta Oncologica · doi:10.1080/02841860802637765 · Cited by 50
High hemoglobin A1c levels within the non‐diabetic range are associated with the risk of all cancers
Goto, A., Noda, M., Sawada, N., Kato, M., Hidaka, A., Mizoue, T., Shimazu, T., Yamaji, T., Iwasaki, M., Sasazuki, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29917 · Cited by 51
Self-citationABO blood type, diabetes and risk of gastrointestinal cancer in northern China
Gong, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i6.563 · Cited by 49
Shuai, Y., Li, C., & Zhou, X. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02304-y · Cited by 49
Papavasileiou, G. E., Tsilingiris, D., Spyrou, N., Vallianou, N. G., Karampela, Ι., Magkos, F., & Dalamaga, Μ. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.03.002 · Cited by 51
Nakamura, A., Tajima, K., Zolzaya, K., Sato, K., Inoue, R., Yoneda, M., Fujita, K., Nozaki, Y., Kubota, K. C., Haga, H., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2703-1 · Cited by 48
Wu, L., Yu, C., Jiang, H., Tang, J., Huang, H., Gao, J., & Zhang, X. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0263 · Cited by 48
Type 2 diabetes mellitus, insulin‐use and risk of bladder cancer in a large cohort study
Newton, C. C., Gapstur, S. M., Campbell, P. T., & Jacobs, E. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27878 · Cited by 48
Diabetes and Lung Cancer Among Postmenopausal Women
Luo, J., Chlebowski, R. T., Wactawski‐Wende, J., Schlecht, N. F., Tinker, L. F., & Margolis, K. L. (2012) · Diabetes Care · doi:10.2337/dc11-2108 · Cited by 48
Rollison, D. E. M., Giuliano, A. R., Sellers, T. A., Laronga, C., Sweeney, C., Risendal, B., Baumgartner, K. B., Byers, T., & Slattery, M. L. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm322 · Cited by 49
Tseng, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142480 · Cited by 47
Association of diabetes mellitus with thyroid cancer risk
Li, H., & Qian, J. (2017) · Medicine · doi:10.1097/md.0000000000008230 · Cited by 47
Iron at the Interface of Hepatocellular Carcinoma
Paganoni, R., Lechel, A., & Spasić, M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084097 · Cited by 48
Lindkvist, B., Almquist, M., Bjørge, T., Stocks, T., Borena, W., Johansen, D., Hallmans, G., Engeland, A., Nagel, G., Jönsson, H., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0096-6 · Cited by 47
Dietary glycemic load and hepatocellular carcinoma with or without chronic hepatitis infection
Rossi, M., Lipworth, L. P., Maso, L. D., Talamini, R., Montella, M., Polesel, J., McLaughlin, J. K., Parpinel, M. T., Franceschi, S., Λάγιου, Π., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp058 · Cited by 47
Cardel, M., Jensen, S. M., Pottegård, A., Jørgensen, T. L., & Hallas, J. (2014) · Cancer Medicine · doi:10.1002/cam4.306 · Cited by 47
Labochka, D., Moszczuk, B., Kukwa, W., Szczylik, C. A., & Czarnecka, A. M. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2776 · Cited by 46
Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysis
Lu, Y., Hajjar, A., Cryns, V. L., Trentham‐Dietz, A., Gangnon, R. E., Heckman‐Stoddard, B. M., & Alagöz, O. (2022) · Cancer Medicine · doi:10.1002/cam4.5545 · Cited by 44
Thompson, A. M., Church, T. S., Janssen, I., Katzmarzyk, P. T., Earnest, C. P., & Blair, S. N. (2008) · Diabetes Care · doi:10.2337/dc07-1648 · Cited by 45
Cardiometabolic factors and breast cancer risk in U.S. black women
Bosco, J. L. F., Palmer, J. R., Boggs, D. A., Hatch, E. E., & Rosenberg, L. A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2131-4 · Cited by 44
Diabetes, Diabetes Treatment, and Risk of Thyroid Cancer
Luo, J., Phillips, L. S., Liu, S., Wactawski‐Wende, J., & Margolis, K. L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3901 · Cited by 44
Body Mass Index as a Predictor of Colorectal Neoplasia in Ethnically Diverse Screening Population
Stein, B. N., Anderson, J. C., Rajapakse, R. O., Alpern, Z. A., Messina, C. R., & Walker, G. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1113-9 · Cited by 43
Kinoshita, M., Kubo, S., Tanaka, S., Takemura, S., Nishioka, T., Hamano, G., Ito, T., Tanaka, S., Ohsawa, M., & Shibata, T. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24223 · Cited by 43
Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review
Biadgo, B., & Abebe, M. (2016) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2016.67.4.168 · Cited by 41
Diabetes mellitus is associated with an increased risk of gastric cancer: a cohort study
Yang, H., Kang, D., Chang, Y., Ahn, J., Ryu, S., Cho, J., Güallar, E., & Sohn, C. I. (2019) · Gastric Cancer · doi:10.1007/s10120-019-01033-8 · Cited by 43
The Dysfunction of NK Cells in Patients with Type 2 Diabetes and Colon Cancer
Piątkiewicz, P., Miłek, T., Bernat-Karpińska, M., Kniotek, M., Czech, A., & Ciostek, P. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0222-5 · Cited by 43
Oberaigner, W., Ebenbichler, C. F., Oberaigner, K., Juchum, M., Schönherr, H. R., & Lechleitner, M. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1058 · Cited by 42
Diabetes mellitus carries a risk of esophageal cancer
Xu, B., Zhou, X., Li, X., Liu, C., & Yang, C. (2017) · Medicine · doi:10.1097/md.0000000000007944 · Cited by 42
Oba, S., Nagata, C., Nakamura, K., Takatsuka, N., & Shimizu, H. (2008) · Journal of Epidemiology · doi:10.2188/jea.je2008004 · Cited by 42
Metadata
- Authors
- Inoue, M.
- Affiliations
- National Cancer Centre Japan (JP)
- Corresponding author
- Inoue, Manami
- ORCID
- Inoue, Manami
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-09-25
- Volume
- 166
- Issue
- 17
- Pages
- 1871
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2096623507
- Cited by
- 561
- References
- 59
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 20 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 28 · 2019: 29 · 2018: 22 · 2017: 35 · 2016: 22 · 2015: 31 · 2014: 41 · 2013: 51 · 2012: 55
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- diabetes mellitus, cancer risk, cancer incidence, liver cancer, pancreatic cancer, kidney cancer, colon cancer, gastric cancer, sex differences, Japan Public Health Center-based Prospective Study, Japanese adults, prospective cohort, hazard ratio, cancer mortality, cancer prevention, lifestyle modification, cancer survivorship, cancer survivorship support services
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Digestive System Neoplasms, Female, Humans, Japan, Male, Middle Aged, Neoplasms, Prospective Studies, Risk Factors, Incidence, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review